SMTL ID : 9fsh.1

Crystal structure of the HECT domain of Smurf 2 in complex with inhibitor 8

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.08 Å

Oligo State

monomer

Ligands

1 x TJQ: ethyl 5-[1,3-benzodioxol-5-ylmethyl(ethyl)carbamoyl]-2,4-dimethyl-1~{H}-pyrrole-3-carboxylate

TJQ.1: 20 residues within 4Å: Chain A: L.127, L.130, R.131, S.197, M.200, L.201, M.241, A.244, V.245, G.248, H.249, Y.250, I.251, G.253, Y.260, F.356, F.368, L.373, I.376, I.377 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:A.244, A:I.251, A:I.251, A:Y.260, A:F.356, A:F.368, A:L.373, A:I.376, A:I.377 Hydrogen bonds: A:H.249, A:I.251 Salt bridges: A:R.131

1 x PO4: PHOSPHATE ION(Non-functional Binders)

PO4.2: 3 residues within 4Å: Chain A: G.142, H.143, R.145 6 PLIP interactions: 6 interactions with chain A Water bridges: A:G.142, A:H.143, A:H.143, A:R.145 Salt bridges: A:H.143, A:R.145

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Rothman, A.M.K. et al., Therapeutic potential of allosteric HECT E3 ligase inhibition. Cell (2025)

Release Date

2025-04-16

Peptides

E3 ubiquitin-protein ligase SMURF2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

E3 ubiquitin-protein ligase SMURF2